.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
US Army
Cerilliant
Daiichi Sankyo
Baxter
Cantor Fitzgerald
Merck
Covington
Chinese Patent Office
QuintilesIMS

Generated: September 26, 2017

DrugPatentWatch Database Preview

DETROL Drug Profile

« Back to Dashboard

Which patents cover Detrol, and what generic Detrol alternatives are available?

Detrol is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. There are three patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in DETROL is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Summary for Tradename: DETROL

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list75
Clinical Trials: see list14
Patent Applications: see list2,590
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DETROL at DailyMed

Pharmacology for Tradename: DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-001Mar 25, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000ABRXYesYes► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000ABRXYesNo► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000ABRXYesYes► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000ABRXYesNo► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000ABRXYesYes► Subscribe► SubscribeY► Subscribe
Pharmacia And Upjohn
DETROL LA
tolterodine tartrate
CAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000ABRXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: DETROL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-001Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-002Mar 25, 1998► Subscribe► Subscribe
Pharmacia And Upjohn
DETROL
tolterodine tartrate
TABLET;ORAL020771-001Mar 25, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for DETROL

Drugname Dosage Strength RLD Submissiondate
tolterodine tartrateTablets1 mg and 2 mgDetrol 
tolterodine tartrateExtended-release Capsules2 mg and 4 mgDetrol LA7/30/2007
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
AstraZeneca
Merck
Teva
Dow
Julphar
Chubb
Citi
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot